Legal
Sanofi, Pfizer Settle California Zantac Case Bound for Trial
- Dispute over cancer was first case slated to go before a jury
- Federal judge threw out more than 5,000 Zantac cases earlier
This article is for subscribers only.
Sanofi SA and Pfizer Inc. have agreed to settle a California man’s lawsuit over Zantac in the first case set for trial on claims the heartburn drug can cause cancer.
Sanofi confirmed the deal Wednesday in a statement, without saying what it had agreed to pay James Goetz to resolve his allegations that Zantac led to his bladder cancer.